Pneumococcal Conjugate Vaccine (PCV) reduced dosing schedule systematic review and meta-analysis Request for proposal
Reference:2023/103/HQ/PCV
Beneficiary countries or territories:Multiple destinations (see the Countries or territories tab)
Published on:12-Jan-2024
Deadline on:12-Feb-2024 23:59 (GMT 1.00)
Description
UPDATE (29 January 2024) - The deadline for submission of offers has been extended to 12 February 2024 from 5 February 2024 (original)
The purpose of this Request for Proposals is to identify a suitable contractor to conduct a systematic review and meta-analysis of studies comparing two dose (1p + 1) pneumococcal conjugate vaccine (PCV) schedules in children with the current WHO recommended three dose schedules. This analysis will inform discussions of the Strategic Advisory Group of Experts on Immunization (SAGE) Pneumococcal Working Group (PCV WG).
See detailed Terms of Reference and bidding instructions under “Documents” below.
Please note: it is NOT necessary to click on “Express Interest” on the top right-hand side of the screen. In order to inform WHO that you are interested in participating in this Request for Proposals, please follow the provisions of the RFP document below.
